Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated:  1/5/2016
Massachusetts General Hospital ACTG CRS
mi
from
Boston, MA
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated: 1/5/2016
Massachusetts General Hospital ACTG CRS
mi
from
Boston, MA
Click here to add this to my saved trials
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated:  1/5/2016
SSTAR, Family Healthcare Ctr.
mi
from
Fall River, MA
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated: 1/5/2016
SSTAR, Family Healthcare Ctr.
mi
from
Fall River, MA
Click here to add this to my saved trials
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated:  1/5/2016
Washington U CRS
mi
from
St. Louis, MO
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated: 1/5/2016
Washington U CRS
mi
from
St. Louis, MO
Click here to add this to my saved trials
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated:  1/5/2016
Beth Israel Med. Ctr. ACTU
mi
from
New York, NY
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated: 1/5/2016
Beth Israel Med. Ctr. ACTU
mi
from
New York, NY
Click here to add this to my saved trials
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated:  1/5/2016
NY Univ. HIV/AIDS CRS
mi
from
New York, NY
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated: 1/5/2016
NY Univ. HIV/AIDS CRS
mi
from
New York, NY
Click here to add this to my saved trials
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated:  1/5/2016
Columbia P&S CRS
mi
from
New York, NY
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated: 1/5/2016
Columbia P&S CRS
mi
from
New York, NY
Click here to add this to my saved trials
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated:  1/5/2016
AIDS Care CRS
mi
from
Rochester, NY
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated: 1/5/2016
AIDS Care CRS
mi
from
Rochester, NY
Click here to add this to my saved trials
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated:  1/5/2016
McCree McCuller Wellness Ctr. at the Connection, Infectious Disease Unit
mi
from
Rochester, NY
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated: 1/5/2016
McCree McCuller Wellness Ctr. at the Connection, Infectious Disease Unit
mi
from
Rochester, NY
Click here to add this to my saved trials
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated:  1/5/2016
Univ. of Rochester ACTG CRS
mi
from
Rochester, NY
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated: 1/5/2016
Univ. of Rochester ACTG CRS
mi
from
Rochester, NY
Click here to add this to my saved trials
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated:  1/5/2016
Unc Aids Crs
mi
from
Chapel Hill, NC
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated: 1/5/2016
Unc Aids Crs
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated:  1/5/2016
Hosp. of the Univ. of Pennsylvania CRS
mi
from
Philadelphia, PA
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated: 1/5/2016
Hosp. of the Univ. of Pennsylvania CRS
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated:  1/5/2016
The Miriam Hosp. ACTG CRS
mi
from
Providence, RI
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion
Status: Enrolling
Updated: 1/5/2016
The Miriam Hosp. ACTG CRS
mi
from
Providence, RI
Click here to add this to my saved trials
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated:  1/6/2016
601 University of California, Los Angeles CARE Center CRS
mi
from
Los Angeles, CA
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated: 1/6/2016
601 University of California, Los Angeles CARE Center CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated:  1/6/2016
701 University of California, San Diego AntiViral Research Center CRS
mi
from
San Diego, CA
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated: 1/6/2016
701 University of California, San Diego AntiViral Research Center CRS
mi
from
San Diego, CA
Click here to add this to my saved trials
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated:  1/6/2016
2701 Northwestern University CRS
mi
from
Chicago, IL
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated: 1/6/2016
2701 Northwestern University CRS
mi
from
Chicago, IL
Click here to add this to my saved trials
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated:  1/6/2016
3201 Chapel Hill CRS
mi
from
Chapel Hill, NC
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated: 1/6/2016
3201 Chapel Hill CRS
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated:  1/6/2016
3652 Vanderbilt Therapeutics (VT) CRS
mi
from
Nashville, TN
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated: 1/6/2016
3652 Vanderbilt Therapeutics (VT) CRS
mi
from
Nashville, TN
Click here to add this to my saved trials
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated:  1/6/2016
Ucsf Aids Crs (801)
mi
from
San Francisco, CA
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated: 1/6/2016
Ucsf Aids Crs (801)
mi
from
San Francisco, CA
Click here to add this to my saved trials
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated:  1/6/2016
Harbor-UCLA Med. Ctr. CRS (603)
mi
from
Torrance, CA
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated: 1/6/2016
Harbor-UCLA Med. Ctr. CRS (603)
mi
from
Torrance, CA
Click here to add this to my saved trials
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated:  1/6/2016
University of Colorado Hospital CRS (6101)
mi
from
Aurora, CO
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated: 1/6/2016
University of Colorado Hospital CRS (6101)
mi
from
Aurora, CO
Click here to add this to my saved trials
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated:  1/6/2016
Rush Univ. Med. Ctr. ACTG CRS (2702)
mi
from
Chicago, IL
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated: 1/6/2016
Rush Univ. Med. Ctr. ACTG CRS (2702)
mi
from
Chicago, IL
Click here to add this to my saved trials
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated:  1/6/2016
Massachusetts General Hospital ACTG CRS (101)
mi
from
Boston, MA
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated: 1/6/2016
Massachusetts General Hospital ACTG CRS (101)
mi
from
Boston, MA
Click here to add this to my saved trials
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated:  1/6/2016
Brigham and Women's Hosp. ACTG CRS (107)
mi
from
Boston, MA
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated: 1/6/2016
Brigham and Women's Hosp. ACTG CRS (107)
mi
from
Boston, MA
Click here to add this to my saved trials
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated:  1/6/2016
Greensboro CRS (3203)
mi
from
Greensboro, NC
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated: 1/6/2016
Greensboro CRS (3203)
mi
from
Greensboro, NC
Click here to add this to my saved trials
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated:  1/6/2016
Univ. of Cincinnati CRS (2401)
mi
from
Cincinnati, OH
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated: 1/6/2016
Univ. of Cincinnati CRS (2401)
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated:  1/6/2016
Case CRS (2501)
mi
from
Cleveland, OH
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated: 1/6/2016
Case CRS (2501)
mi
from
Cleveland, OH
Click here to add this to my saved trials
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated:  1/6/2016
Houston AIDS Research Team CRS (31473)
mi
from
Houston, TX
Modulation of Immune Activation by Aspirin
Modulation of Immune Activation by Aspirin
Status: Enrolling
Updated: 1/6/2016
Houston AIDS Research Team CRS (31473)
mi
from
Houston, TX
Click here to add this to my saved trials
Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP)
A Pilot Project to Assess the Safety and Tolerability of Truvada Plus Raltegravir as Post-exposure Prophylaxis (nPEP) Following Sexual Exposure to Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  1/7/2016
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP)
A Pilot Project to Assess the Safety and Tolerability of Truvada Plus Raltegravir as Post-exposure Prophylaxis (nPEP) Following Sexual Exposure to Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 1/7/2016
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated:  1/7/2016
UCLA David Geffen School of Medicine
mi
from
Los Angeles, CA
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated: 1/7/2016
UCLA David Geffen School of Medicine
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated:  1/7/2016
University of California
mi
from
San Diego, CA
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated: 1/7/2016
University of California
mi
from
San Diego, CA
Click here to add this to my saved trials
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated:  1/7/2016
University of Colorado- Health Science Center
mi
from
Denver, CO
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated: 1/7/2016
University of Colorado- Health Science Center
mi
from
Denver, CO
Click here to add this to my saved trials
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated:  1/7/2016
The Ponce de Leon Ctr. CRS
mi
from
Atlanta, GA
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated: 1/7/2016
The Ponce de Leon Ctr. CRS
mi
from
Atlanta, GA
Click here to add this to my saved trials
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated:  1/7/2016
Northwestern University CRS
mi
from
Chicago, IL
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated: 1/7/2016
Northwestern University CRS
mi
from
Chicago, IL
Click here to add this to my saved trials
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated:  1/7/2016
Johns Hopkins School of Medicine
mi
from
Baltimore, MD
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated: 1/7/2016
Johns Hopkins School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated:  1/7/2016
Massachusetts General Hospital, Division of Infectious Diseases
mi
from
Boston, MA
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated: 1/7/2016
Massachusetts General Hospital, Division of Infectious Diseases
mi
from
Boston, MA
Click here to add this to my saved trials
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated:  1/7/2016
Henry Ford Hosp. CRS
mi
from
Detroit, MI
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated: 1/7/2016
Henry Ford Hosp. CRS
mi
from
Detroit, MI
Click here to add this to my saved trials
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated:  1/7/2016
Washington University
mi
from
St. Louis, MO
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated: 1/7/2016
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated:  1/7/2016
NYU Med Ctr, Dept of Medicine
mi
from
New York, NY
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated: 1/7/2016
NYU Med Ctr, Dept of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated:  1/7/2016
1101 University of Rochester Medical Center, Division of Infectious Diseases
mi
from
Rochester, NY
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated: 1/7/2016
1101 University of Rochester Medical Center, Division of Infectious Diseases
mi
from
Rochester, NY
Click here to add this to my saved trials
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated:  1/7/2016
University of North Carolina AIDS Clinical Trials Unit
mi
from
Chapel Hill, NC
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated: 1/7/2016
University of North Carolina AIDS Clinical Trials Unit
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated:  1/7/2016
The Research & Education Group-Portland CRS
mi
from
Portland, OR
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated: 1/7/2016
The Research & Education Group-Portland CRS
mi
from
Portland, OR
Click here to add this to my saved trials
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated:  1/7/2016
University of Pennsylvania, ACTU
mi
from
Philadelphia, PA
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated: 1/7/2016
University of Pennsylvania, ACTU
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated:  1/7/2016
Virginia Commonwealth Univ. Medical Ctr. CRS
mi
from
Richmond, VA
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated: 1/7/2016
Virginia Commonwealth Univ. Medical Ctr. CRS
mi
from
Richmond, VA
Click here to add this to my saved trials
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated:  1/7/2016
University of Washington; Harborview Medical Center
mi
from
Seattle, WA
Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Status: Enrolling
Updated: 1/7/2016
University of Washington; Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase I One-month Safety, PK, PD, and Acceptability Study of IVR Releasing TFV and LNG or TFV Alone
Phase I One-Month Safety, Pharmacokinetic, Pharmacodynamic, and Acceptability Study of Intravaginal Rings Releasing Tenofovir and Levonorgestrel or Tenofovir Alone
Status: Enrolling
Updated:  1/8/2016
Eastern Virginia Medical School
mi
from
Norfolk, VA
Phase I One-month Safety, PK, PD, and Acceptability Study of IVR Releasing TFV and LNG or TFV Alone
Phase I One-Month Safety, Pharmacokinetic, Pharmacodynamic, and Acceptability Study of Intravaginal Rings Releasing Tenofovir and Levonorgestrel or Tenofovir Alone
Status: Enrolling
Updated: 1/8/2016
Eastern Virginia Medical School
mi
from
Norfolk, VA
Click here to add this to my saved trials
Phase I One-month Safety, PK, PD, and Acceptability Study of IVR Releasing TFV and LNG or TFV Alone
Phase I One-Month Safety, Pharmacokinetic, Pharmacodynamic, and Acceptability Study of Intravaginal Rings Releasing Tenofovir and Levonorgestrel or Tenofovir Alone
Status: Enrolling
Updated:  1/8/2016
Profamilia
mi
from
Santo Domingo,
Phase I One-month Safety, PK, PD, and Acceptability Study of IVR Releasing TFV and LNG or TFV Alone
Phase I One-Month Safety, Pharmacokinetic, Pharmacodynamic, and Acceptability Study of Intravaginal Rings Releasing Tenofovir and Levonorgestrel or Tenofovir Alone
Status: Enrolling
Updated: 1/8/2016
Profamilia
mi
from
Santo Domingo,
Click here to add this to my saved trials
Treatment of Acute HIV Infection With Quad Fixed-dose Combination (FDC) Tablet
Treatment of Acute HIV Infection With the Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate, A Pilot Study of Response to Therapy and HIV Pathogenesis
Status: Enrolling
Updated:  1/11/2016
UNC Chapel Hill
mi
from
CHapel Hill, NC
Treatment of Acute HIV Infection With Quad Fixed-dose Combination (FDC) Tablet
Treatment of Acute HIV Infection With the Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate, A Pilot Study of Response to Therapy and HIV Pathogenesis
Status: Enrolling
Updated: 1/11/2016
UNC Chapel Hill
mi
from
CHapel Hill, NC
Click here to add this to my saved trials
Treatment of Acute HIV Infection With Quad Fixed-dose Combination (FDC) Tablet
Treatment of Acute HIV Infection With the Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate, A Pilot Study of Response to Therapy and HIV Pathogenesis
Status: Enrolling
Updated:  1/11/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Treatment of Acute HIV Infection With Quad Fixed-dose Combination (FDC) Tablet
Treatment of Acute HIV Infection With the Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate, A Pilot Study of Response to Therapy and HIV Pathogenesis
Status: Enrolling
Updated: 1/11/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
N-acetylcysteine to Reduce Oxidative Stress and Improve Endothelial Function in HIV-infected Older Adults
A Randomized, Placebo-Controlled Pilot Trial Assessing Two Doses of N-Acetylcysteine on Changes in Oxidative Stress and Endothelial Function in HIV-infected Older Adults Receiving Stable Antiretroviral Therapy
Status: Enrolling
Updated:  1/11/2016
Indiana University Health University Hospital, Indiana Clinical Research Center
mi
from
Indianapolis, IN
N-acetylcysteine to Reduce Oxidative Stress and Improve Endothelial Function in HIV-infected Older Adults
A Randomized, Placebo-Controlled Pilot Trial Assessing Two Doses of N-Acetylcysteine on Changes in Oxidative Stress and Endothelial Function in HIV-infected Older Adults Receiving Stable Antiretroviral Therapy
Status: Enrolling
Updated: 1/11/2016
Indiana University Health University Hospital, Indiana Clinical Research Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Usc La Nichd Crs
mi
from
Alhambra, CA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Usc La Nichd Crs
mi
from
Alhambra, CA
Click here to add this to my saved trials